Meet our leadership team

Board Members

"I would like to thank our shareholders for their continued support and our employees all over the globe for their dedication, skills and professionalism that has brought BATM to this exciting position and will continue to move us toward growth and profitability. As always, we are committed to creating value for our shareholders in the years to come and look forward to continuing to report our progress."

Dr. Gideon Chitayat
Non-executive Chairman

Dr. Gideon Chitayat
Non-executive Chairman

Dr. Gideon Chitayat is the Chairman and CEO of GMBS Ltd, a strategic consulting firm. He has served as the Chairman of Delta Galil Industries and as a director of Milissron Shopping malls, Paz Oil Company, Teva Israel Pharmaceutical Industries, Bank Hapoalim and Israel Aircraft Industries, and has provided consultancy services in business strategy to the boards and presidents of large companies. He has also served as Adjunct Professor at Tel Aviv University, Recanati Business School. Dr. Chitayat holds a Ph.D. in Business & Applied Economics from the University of Pennsylvania, Wharton School and a Master’s in Business & Applied Economics from the Hebrew University, Jerusalem. Dr. Chitayat joined the Board of BATM in June 2010 and was appointed Chairman in January 2015. He was re-elected as a Director of the Board in December 2024.

Moti Nagar
Executive Director & CEO

Moti Nagar has been the CEO of BATM since 1 January 2023, having been the CFO since 2015. During his time at BATM, Mr. Nagar has been instrumental in driving the business' development, including leading several M&A transactions, the Group's IPO on TASE and, since his appointment as CEO, renewing the Group's strategy. Prior to BATM, Mr. Nagar held several senior positions at Deloitte, which he joined in 2005. As a Senior Manager, Mr. Nagar was responsible for handling the accounts of leading corporate clients in Israel and overseas, with companies traded on the LSE, NASDAQ and TASE as well as private businesses operating in a range of sectors. Mr. Nagar is a member of the Managing Board of the Israeli Association of Publicly Traded Companies, a non-profit organisation representing hundreds of companies listed on the Tel Aviv Stock Exchange and other stock exchanges throughout the world. Mr. Nagar graduated in Business Management and Accounting and qualified as an Israeli Certified Public Accountant (CPA, Israel) in 2008. He also holds an MBA in Financial Management from Tel Aviv University. He was re-elected as a Director of the Board in December 2024.

Lior Miles
Executive Director & CFO

Lior Miles was appointed CFO of BATM on 23 June 2025, bringing over 15 years' experience in financial management for public and private companies operating globally primarily in the technology industry, including serving as VP Finance of BATM from 2015-2021. Mr. Miles joined BATM from Kenes Group where, as Group CFO, he oversaw financial operations, including investments, cash management, risk management, insurance, M&A, taxation and financial strategy, for the global operations across 18 locations on four continents. Other experience includes being Director of Finance for Abra Information Technologies Ltd., a TASE-listed provider of IT services and solutions, and its subsidiaries in the US and Israel.

Mr. Miles is an Israeli Certified Public Accountant who commenced his career as an accountant at PwC, where he performed company audits in accordance with US GAAP and IFRS standards. He holds a BA in Accounting and Economics and an MA in Accounting from Bar Ilan University.

Prof. Varda Shalev
Non-executive Director

Prof. Varda Shalev is a specialist in epidemiology, medical informatics and predictive analytics in community healthcare. She was a founder and director of the Morris Kahn & Maccabi Institute for Health Research and Innovation and is an active primary care physician. She has pioneered the development of multiple disease registries to support chronic disease management, and has authored or co-authored over 200 publications in peer-reviewed medical journals.

She is a Managing Partner of Team8 Health, a medtech-focused venture capital company, and a director of Teva Pharmaceutical Industries Ltd. In addition, she is a Professor at the Tel Aviv University School of Public Health and sits on the advisory board of several med-tech businesses. She was appointed to the Board of BATM in November 2018 and her third three-year term, in accordance with Israeli law, was approved by shareholders in December 2024.

Dr. Avigdor Shafferman
Non-executive Director

Dr. Avigdor Shafferman had an established career at the Israel Institute for Biological Research, a leading governmental applied research institute specialising in the fields of biology, medicinal chemistry and environmental sciences, where he worked for almost 40 years. He is a recipient of several prestigious scientific awards and author of over 200 scientific papers. Most recently, from 1995 until his retirement in 2013, he was General Director of the organisation. Other roles have included serving as a visiting professor in the University of California, San Diego at the biology department as well as a visiting senior research scientist at various leading research institutions in the United States in various medical areas, including vaccines. Dr. Shafferman holds a Ph.D. in physical chemistry from the Hebrew University of Jerusalem.
He was re-elected as a Director of BATM in December 2024.

Dr. Shmuel Ben Zvi
Non-executive Director

Dr. Shmuel (Muli) Ben Zvi was elected as a Director of BATM in December 2024. He has extensive executive and board experience across multiple industries, including nine years as a director of Bank Leumi, the largest banking corporation in Israel, and being elected Chairman of the board in October 2023 for the final year of his tenure. At Bank Leumi, he was a member of the board’s audit, risk management, credit, technology and strategy committees. Dr. Ben Zvi is currently a director of Protalix Biotherapeutics (NYSE American: PLX) and previously of Sol-Gel Technologies (NASDAQ: SLGL) and VBL Therapeutics (NASDAQ: VBLT). From 2004 to 2014, he held a number of managerial positions at Teva Pharmaceuticals (NASDAQ and TASE: TEVA), including Vice President of Strategy and Vice President of Finance.

Gil Sharon
Non-executive Director

Gil Sharon brings over 30 years' experience in the telecommunications industry. He is currently Chairman of IBC, an Israeli fibre optic communications company. Prior to IBC, he was Executive Chairman of Bezeq The Israeli Telecommunications Corporation Ltd (TASE: BEZQ), the largest telecommunications group in Israel, and Chairman of its subsidiaries: Pelephone, a mobile network operator; Yes, a television and internet service provider; and Bezeq International, a business internet services, international communication, integration and IT solutions company. Other roles have included Chairman, CEO and co-investor of Golan Telecom.

Ayala Hakim
Non-executive Director

Ayala Hakim is a director of Bank Yahav, which is a retail bank in Israel that was established in 1954. She served as the Chief Information Officer of Mizrahi-Tefahot Bank Ltd., one of Israel's largest financial institutions, and CEO of its technology division from 2013 until 2025. During her tenure, she led large-scale digital transformations, enterprise IT strategy - including harnessing and leveraging technology to implement the bank's business strategy and create new business opportunities - and complex system integrations. Prior to joining Mizrahi-Tefahot Bank, Ayala spent over 30 years in leadership roles focusing on technology and IT for the Israeli government.